SPOTLIGHT -
NDA for Investigational Schizophrenia Treatment Submitted to FDA
The NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
Implementing a Year-Long Vaccine Program Helps Community Pharmacies Increase Profits
By offering vaccines year-round instead of only during the typical flu season, community pharmacies can maximize profits and help patients live healthier lives.
RPhCast, Episode Four: Finding Satisfaction In A Pharmacy Career
Kevin is joined by Dr. Thea Blystone, PharmD for a talk about finding fulfillment and satisfaction in the pharmacy world, plus how to find balance between serving others and having time for yourself.
Adalimumab Biosimilar Now Available at Significant Discount to Humira
Boehringer Ingelheim’s unbranded adalimumab-adbm biosimilar will be available at an 81% discount to adalimumab (Humira).
Biologics Offer Great Results in Treating Psoriasis—At a Cost
Highly effective medications for severe disease are expensive and administered invasively, whereas the development of treatments for milder disease has lagged.